• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during breastfeeding and pregnancy is challenging for women with the condition. There aren't enough data on how exposure to ADHD for a long time could affect a pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Pregnant women who use ADHD medications must weigh the benefits of taking them against potential risks to the fetus. Doctors don't have enough data to provide clear recommendations, but can provide information on the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy were not at a higher risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy and those who had not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure an accurate case classification and to minimize the chance of bias.

The study of the researchers had some limitations. Researchers were unable, in the first place to differentiate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to the use of medications, or if they were caused by comorbidities. Researchers also did not study the long-term effects for the offspring.

The study did reveal that infants whose mothers took adhd medication pregnancy (This Web page) medication during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had stopped their medications before or during pregnancy. The reason for this was central nervous system disorders, and the increased risk for admission was not found to be affected by the type of stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during early pregnancy may be offset by the greater benefits to both mother and child of continuing treatment for the woman's condition. Physicians should discuss the issue with their patients and, when they are able, assist them in developing strategies to improve coping skills which can reduce the effects of her disorder on her daily functioning and relationships.

Interactions with Medication

As more women than ever before are being diagnosed with adhd medication not working and being treated with medication, the issue of whether to keep or discontinue treatment during pregnancy is a question that doctors are having to have to face. These decisions are often made without clear and authoritative evidence. Instead, physicians must consider their own expertise, the experience of other doctors and the research on the topic.

In particular, the issue of potential risks for the infant can be difficult. The research that has been conducted on this topic is based on observations rather than controlled studies and the results are contradictory. In addition, most studies limit their analysis to live births, which could underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study presented in the journal club addresses these issues by analyzing information on deceased and live births.

The conclusion: While some studies have shown a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection and the majority of studies show a neutral or even slight negative effect. Therefore, a careful risk/benefit analysis is required in every case.

For women suffering from ADHD, the decision to stop medication is difficult if not impossible. In fact, in a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation and family conflict for those suffering from the disorder. A loss of medication may also impact the ability to drive safely and complete work-related tasks, which are crucial aspects of everyday life for those with ADHD.

She recommends women who are unsure about whether to keep or discontinue medication due to their pregnancy, consider the possibility of educating friends, family members, and coworkers on the condition, its effects on daily functioning, and on the advantages of continuing the current treatment regimen. It can also help a woman feel confident about her decision. Certain medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her baby.

Birth Defects and Risk of

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) is increasing as does the concern about the potential adverse effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers used two huge data sets to study over 4.3 million pregnancy and determine if stimulant medication use increased the risk of birth defects. Although the risk overall is low, the researchers did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects, such as ventriculo-septal defect (VSD).

The researchers behind the study found no link between the use of early medications and congenital abnormalities such as facial clefting or club foot. The results are in agreement with previous studies which showed an insignificant, but small increase in cardiac malformations genetic testing for adhd medications women who began taking ADHD medication prior to the time of pregnancy. The risk was higher in the later part of pregnancy, when a lot of women begin to discontinue their ADHD medication.

Women who were taking ADHD medication during the first trimester were more likely require a caesarean delivery, have a low Apgar after delivery, and have a baby that needed help breathing at birth. However the researchers of the study were unable to eliminate selection bias by restricting the study to women who didn't have any other medical issues that could have contributed to these findings.

Researchers hope their research will inform physicians when they encounter pregnant women. The researchers suggest that while discussing risks and benefits are important, the choice about whether to continue or stop medication should be according to the severity of each woman's ADHD symptoms and her requirements.

The authors also advise that even though stopping the medication is an alternative, it is not an option that is recommended due to the high prevalence of depression and other mental health problems in women who are pregnant or postpartum. Additionally, the research suggests that women who decide to stop taking their medications are more likely to have difficulties adapting to life without them following the birth of their baby.

Nursing

The responsibilities of a new mother can be overwhelming. Women with ADHD who have to deal with their symptoms while attending doctor appointments as well as making preparations for the arrival of their child and adjusting to new household routines may face a lot of challenges. Many women decide to continue taking their adhd medications for adults medication during pregnancy.

The risk to a breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk at low levels. However, the frequency of exposure to medications by the infant can differ based on dosage, how to get adhd medication uk often it is taken and the time of the day it is administered. In addition, various drugs enter the infant's system via the gastrointestinal tract or through breast milk. The impact on the health of a newborn is not fully comprehended.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult decision for the patient, who must weigh the benefits of keeping her medication against the possible risks to the fetus. Until more information is available, GPs should ask all pregnant patients about their history of ADHD and if they are planning or taking to take medication during the perinatal time.

Many studies have shown that women can continue taking their ADHD medication without risk while breastfeeding and during pregnancy. As a result, many patients choose to do so and in consultation with their physician, they have discovered that the benefits of continuing their current medication outweigh any potential risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non stimulant adhd medication list-pharmacological strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also be informed about treatment options and strengthen coping mechanisms. This should be an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.